Kewaunee Scientific Corporation
Rank #105HypergrowthKEQU · Nasdaq · Consumer Cyclical
Kewaunee Scientific Corporation (KEQU) — Rank #105 by gross profitability (GP/assets 0.45) · ROE 12.9% · Piotroski F-Score 5 / 9.
As-of 2026-09-15 · CIK 0000055529 · all metrics point-in-time as of the filing date.
About
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally.
Show moreShow less
It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products. It also provides facility design, detailed engineering, construction, and project management services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets; and its technical products are used in facilities manufacturing computers and light electronics, and by users of computer and networking furniture. It sells its products through dealers, its subsidiaries, and a national stocking distributor.
Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
- Industry
- Furnishings, Fixtures & Appliances
- Sector
- Consumer Cyclical
- State
- DE
- Filer Category
- Non-accelerated filerSmaller reporting company
- Fiscal Year End
- April 30
- Website
- kewaunee.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2022-04-30filed 2022-07-01 | 2021-04-30filed 2021-07-15 | 2020-04-30filed 2020-07-27 | 2019-04-30filed 2019-07-11 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 2.8 | 2.7 | 2.7 | 2.6 |
| Stock-based compensation | 0.7 | 0.6 | 0.3 | 0.2 |
| Change in receivables | 8.5 | 6.1 | (4.8) | 0.7 |
| Change in inventory | 7.3 | 1.2 | (1.9) | (0.5) |
| Operating cash flow | (7.9) | 0.9 | 4.2 | 2.5 |
| Investing | ||||
| Capital expenditures | 1.9 | 2.4 | 2.5 | 4.2 |
| Investing cash flow | (1.9) | (2.4) | (2.5) | (4.2) |
| Financing | ||||
| Debt issued | 0.4 | — | — | — |
| Debt repaid | 0.0 | 0.0 | 1.3 | 1.2 |
| Dividends paid | — | 0.0 | 1.0 | 2.0 |
| Financing cash flow | 11.0 | 2.0 | (7.5) | 2.3 |
| Summary | ||||
| Free cash flow | (9.8) | (1.5) | 1.7 | (1.7) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?